Endothelial HSPA12B regulates myocardial monocyte infiltration and inflammatory activity after myocardial infarction

Yana Wang1, Min Fan1,2, Linjian Chen1

  • 1Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.

PubMed

Insights

Endothelial cell-specific heat shock protein A12B (eHSPA12B) regulates immune cell responses after myocardial infarction (MI). eHSPA12B controls monocyte infiltration and macrophage activation, improving cardiac function post-MI.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cell Biology

Background:

  • Cardiac macrophages are crucial for inflammation and tissue repair after myocardial infarction (MI).
  • Endothelial cell-specific heat shock protein A12B (eHSPA12B) is a known vascular regulator, but its role in post-MI immune responses is unclear.

Purpose of the Study:

  • To investigate the role of eHSPA12B in regulating monocyte infiltration and immune cell activation following MI.
  • To elucidate the underlying mechanisms of eHSPA12B-mediated immune modulation in the context of cardiac injury.

Main Methods:

  • Utilized endothelial cell-specific Hspa12b knockout (eHspa12b-/-) and wild-type (WT) mice to model MI.
  • Assessed cardiac function, monocyte infiltration, and macrophage phenotypes via flow cytometry, ELISA, and Western blotting.
  • Investigated the role of endothelial cell-derived exosomes carrying HSPA12B in modulating macrophage polarization and TLR4/MyD88 signaling.

Main Results:

  • eHspa12b-/- mice showed impaired cardiac function and increased monocyte infiltration post-MI compared to WT controls.
  • HSPA12B secreted by endothelial cells via exosomes promoted a pro-regenerative macrophage phenotype.
  • HSPA12B-containing exosomes induced macrophage polarization by promoting TLR4 and MyD88 degradation.

Conclusions:

  • Endothelial HSPA12B plays a significant immunomodulatory role in controlling monocyte infiltration and immune activation after MI.
  • Targeting eHSPA12B presents a potential therapeutic strategy for improving cardiac repair and function following myocardial infarction.
Abstract